Stocks
Senti Biosciences, Inc.SNTI
NASDAQHealthcareBiotechnology$0.98
Develops engineered cell and gene therapies using synthetic biology to program immune cells with gene circuits that can better detect and attack disease. The company is advancing a pipeline of off-the-shelf cell therapies, including CAR-NK programs targeting cancer and other indications. Investors m...
52W Range: $0.80 – $5.10
Congressional Interest in Senti Biosciences, Inc. (SNTI)
8 members of Congress have disclosed 12 trades in Senti Biosciences, Inc. (SNTI), a Healthcare company. The buy/sell breakdown shows 6 purchases versus 6 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
12
Unique Politicians
8
Buys
6
Sells
6
Who in Congress Is Trading SNTI?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-09-25 | Rohit Khanna | buy | $1K – $15K |
| 2012-12-01 | TULSI GABBARD | sell | $100K – $250K |